Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

SCLXW SCILEX HOLDING COMPANY C/WTS 10/11/2027 (TO PUR COM)

Watchlist
1.720
+0.210+13.91%
Close  01/27 16:00 ET
1.7200.0000.00%
Post Mkt Price 01/27 16:00 ET
High
2.100
Open
1.640
Turnover
272.80K
Low
1.640
Pre Close
1.510
Volume
151.83K
Market Cap
0
P/E(TTM)
0.00
52wk High
2.100
Shares
0
P/E(Static)
0.00
52wk Low
0.120
Float Cap
0
Bid/Ask %
-33.33%
Historical High
2.100
Shs Float
0
Volume Ratio
0.89
Historical Low
0.120
Dividend TTM
--
Div Yield TTM
--
P/B
0.00
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.00%
Amplitude
30.47%
Avg Price
1.796
Lot Size
1
Float Cap
0
Bid/Ask %
-33.33%
Historical High
2.100
Shs Float
0
Volume Ratio
0.89
Historical Low
0.120
Dividend TTM
--
P/B
0.00
Dividend LFY
--
Turnover Ratio
0.00%
Amplitude
30.47%
Avg Price
1.796
Lot Size
1
Price Forecast

News

Comment

No Data

Company Overview More
Scilex Holding Co. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. Its products include ZTlido, a prescription lidocaine topical product approved by the FDA for the relief of neuropathic pain associated with PHN, which is a form of post-shingles nerve pain, and e GLOPERBA oral solutions, an FDA-approved prophylactic treatment for painful gout flares in adults. The company was founded on February 21, 2020 and is headquartered in Palo Alto, CA.
CEO: Mr. Jaisim Shah
Market: NASDAQ
Listing Date: 01/07/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist